2 recruiting, 1 completed, 1 not yet recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 2, Completed 1, Not yet recruiting 1 |
Follow Stimulant Use Disorder: new trials by email Literature Review of Stimulant Use Disorder trials Research Report on Stimulant Use Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study PEX010-Assisted Therapy, PEX010(01) - Stimulant Use Disorder | Phase 2 | Not yet recruiting | Filament Health Corp. | 86 | 2025-01-01 | 2024-10-30 |
| Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder SUVO, TAU - Stimulant Use Disorder | Phase 2 | Recruiting | The University of Texas Health Science Center, Houston | 20 | 2024-07-25 | 2025-09-05 |
| Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treatment Mirtazapine, Placebo - Stimulant Use Disorder | Phase 2 | Recruiting | Washington State University | 60 | 2024-06-17 | 2026-07-02 |
| Suvorexant for Opioid/Stimulant Co-use Suvorexant (dual orexin receptor antagonist), Placebo - Opioid Use Disorder, Stimulant Use Disorder | Phase 2 | Completed | Johns Hopkins University | 20 | 2022-12-01 | 2025-12-23 |
Substance-Related Disorders (2) · Chemically-Induced Disorders (1) · Narcotic-Related Disorders (1) · Opioid-Related Disorders (1)
Mental Disorders (2) · Chemically-Induced Disorders (1)
Mirtazapine (1) · Orexin Receptor Antagonists (1) · suvorexant (1)
Filament Health Corp. (1) · Johns Hopkins University (1) · The University of Texas Health Science Center, Houston (1) · Washington State University (1)
United States (3)
Heather Webber, PhD (1) · Jennifer Ellis, Ph.D. (1) · Sterling M McPherson, PhD (1)